Figure 2 — KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway

Research Paper|Volume 11, Issue 24|pp. 11905–11921

KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway

Back to articleFigure 2(2 of 7)

100%

Figure 2.KIF20A is a prognostic predictor in CRC. (A) Survival analysis of CRC patients with high/low expression of KIF20A based on the data from GSE17536. (B) Survival analysis of CRC patients with high/low expression of KIF20A based on the data from GSE17538. (C) Survival analysis of CRC patients with high/low expression of KIF20A based on the data from TCGA.